Larry Lyons

Open-label, Phase I Study of Nivolumab Combined with <i>nab</i> -Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer

Zev A. Wainberg, Howard S. Höchster, Edward Kim et al. · Clinical Cancer Research · 2020 · 154 citations

Medicine, Oncology, Pharmacology +17

BLT-D (Clarithromycin [Biaxin], Low-Dose Thalidomide, and Dexamethasone) for the Treatment of Myeloma and Waldenström's Macroglobulinemia

Morton Coleman, John P. Leonard, Larry Lyons et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2002 · 79 citations

Medicine, Pharmacology, Pharmacotherapy +13

Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone

Morton Coleman, John P. Leonard, Larry Lyons et al. · Seminars in Oncology · 2003 · 56 citations

Pharmacy, Pharmacology, Pharmacotherapy +3

Phase I study of nivolumab (Nivo) + <i>nab</i>-paclitaxel (<i>nab</i>-P) + gemcitabine (Gem) in advanced pancreatic cancer (APC).

Zev A. Wainberg, Howard S. Höchster, Edward Kim et al. · Journal of Clinical Oncology · 2019 · 29 citations

Medicine, Oncology, Pharmacology +17

Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer

Jonathan W. Goldman, David Waterhouse, Ben George et al. · Frontiers in Oncology · 2019 · 12 citations · Full text

Medicine, Oncology, Pharmacology +16